Relay Therapeutics
Ermira Pazolli is a seasoned biologist with extensive experience in oncology and pharmacology. As the Vice President and Head of Biology at Relay Therapeutics since October 2018, Ermira has held multiple leadership roles and has been instrumental in driving research initiatives. Prior experience includes serving as a Senior Investigator at H3 Biomedicine, where Ermira led biology-focused programs and supervised complex projects in a matrix environment. Previous roles at AstraZeneca involved innovative research in breast cancer and lymphoma, while early career research at Washington University and Brigham Young University focused on the mechanisms of cellular senescence and plasmid behavior, respectively. Ermira holds a Ph.D. in Molecular Cell Biology from Washington University and a B.S. in Microbiology from Brigham Young University.
This person is not in any teams
This person is not in any offices
Relay Therapeutics
2 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.